⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GSK News
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
The International Myeloma Foundation Wants You to #KnowMyeloma for Blood Cancer Awareness Month 2026
globenewswire.com
BMY
GSK
U.S. FDA approves ViiV Healthcare’s Tivicay PD, helping close a critical HIV treatment gap for young children
businesswire.com
GSK
Vivace Therapeutics Strengthens Leadership Team as It Prepares to Advance VT3989, the First TEAD Inhibitor to enter Phase 3 Clinical Trials, as the Leading Treatment for Mesothelioma
prnewswire.com
GILD
GSK
Blood Cancer Therapeutics Market to Reach $125.5 Billion by 2030, Driven by Precision Medicine Advances and Expanding Immunotherapy Pipelines
globenewswire.com
ABBV
AMGN
AZN
BMY
ROG
GILD
GSK
JNJ
LLY
MRK
NVS
SNY
PFE
JAZZ
AMRX
Global Ranitidine Market (2026-2031) - Rising Prevalence of Gastroesophageal Reflux Disease and Peptic Ulcers Drives Growth
globenewswire.com
GSK
MRK
SNY
TEVA
VTRS
Polypill Products Market (2026-2031) - Rising Cardiovascular Disease Burden and Need for Improved Medication Adherence to Drive Growth
globenewswire.com
ABT
AZN
CI
RDY
GSK
JNJ
LPCN
MRK
NVS
PFE
SNY
SUN
TEVA
VTRS
State of the Life Sciences Industry to Be Reviewed in BCC Research's 2026 Second Quarter Outlook, Spotlighting AI-Driven Discovery, Precision Oncology, and Connected Health Adoption
globenewswire.com
TEVA
AZN
GSK
NVS
PFE
JNJ
BMY
MRK
LLY
REGN
ILMN
CHTR
EVO
AMGN
ABT
GH
Dravet Syndrome Market Trends Indicate Sustained Growth During the Forecast Period (2026–2036), Driven by Novel Treatment Approaches | DelveInsight
globenewswire.com
BIIB
HRMY
XNCR
AZN
LLY
PFE
REGN
NVS
TSLA
TAK
GSK
JNJ
UCB
BHF
PRAX
XENE
AQST
TNDM
INCY
MRK
ABBV
BMY
AMGN
GILD
VRTX
CRSP
EDIT
NTLA
SRPT
ALNY
EXAS
TEVA
AXSM
CYTK
INSM
KODK
LPCN
MNKD
NBIX
NCLH
ONCY
ORIC
PBYI
PEGA
PLRX
PRGS
QGEN
RGNX
ROST
RYAAY
SNOW
SWKS
SYK
TGT
TRMB
TXG
ULTA
VRSK
WDC
WVE
XOM
ZBRA
ZNTL
ZTS
STOK
IONS
MOMO
BBAR
CTXR
MBIO
GNS
NEON
OVID
BHVN
Amplifica Appoints Hans Hofland, Ph.D., as Chief Development Officer and William Humphries to Board of Directors
prnewswire.com
ACRS
ALC
AMGN
BCRX
BIIB
BMY
CRSP
CTRA
CYTK
DASH
EXAS
GILD
GSK
INCY
JNJ
KDP
LULU
MRNA
NBIX
NVS
OCGN
ORCL
PFE
REGN
ROST
RVMD
SNOW
SRPT
STRL
TGTX
TMO
TRMB
TSLA
TXG
VRTX
XOM
ZBRA
Global Neurodiagnostics Market to Accelerate Substantially at a CAGR of ~7% by 2034 | DelveInsight
globenewswire.com
ABBV
AMRN
AXSM
BMY
BIIB
BSX
LLY
GSK
JNJ
MDT
NVS
NVO
SNPS
SUPN
TMO
ABT
XOM